asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

Mesothelioma

Recent Posts in Mesothelioma Category

130 results found. Viewing page 1 of 6. Go to page 1 2 3 4 5 6   Next
Sep 15 2022

Study Utilizing 'Drug Factory' Implants Destroy Mesothelioma Tumors in Mice

Researchers from Rice University and Baylor College of Medicine have managed to eradicate advanced-stage mesothelioma tumors within days on rodent subjects, laying the groundwork for future human trials. By combining cytokine “drug ...

Continue Reading...
Aug 18 2022

Justice for Asbestos Victims: The Removal Adjustment Act

U.S. Representative Elaine Luria of Virginia has introduced legislation to prohibit state courts from removing cases to the federal court system. Throughout the United States, when asbestos victims seek restitution from the companies that knowingly ...

Continue Reading...
Jul 28 2022

Register Now for PMC's 11th Annual 5k Walk/Hike for Mesothelioma and Get Fundraising!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is less than a month away! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills (family and animal ...

Continue Reading...
Jul 21 2022

FDA Grants Fast Trak Status to Novel Therapy for Patients with Unresectable NF2-Deficient Malignant Pleural Mesothelioma

The U.S. Food and Drug Administration (FDA) has designated Fast Track status to a new therapeutic drug therapy for the treatment of malignant pleural mesothelioma (MPM) in patients with unresectable NF2-deficient tumors. The drug, IK-930, was granted ...

Continue Reading...
Jun 9 2022

Galinpepimut-S in the Treatment of Late-Stage Pleural Mesothelioma

SELLAS Life Sciences Group (SELLAS) has announced promising results of a Phase 1 clinical trial of the combination of immunotherapy agents Galinpepimut-S (GPS) and nivolumab for patients with WT1 positive malignant pleural mesothelioma. GPS is an ...

Continue Reading...
Jun 6 2022

Researchers Seek to Develop Inhalable Treatment Option for Mesothelioma & Non-Small Cell Lung Cancer

Researchers in Japan are working to develop an inhalable powder as a new form of treatment for non-small cell lung cancer and mesothelioma. The inhalable powder is a form of gene therapy containing tumor suppression drugs SFD-p16 and SFD-p53 which ...

Continue Reading...
Jun 2 2022

Mesothelioma Deaths Among Women Increases

Despite the overall decreased use of asbestos nationwide, mesothelioma deaths among women still managed to increase by 25% over the past two decades. This according to death record statistics published by the Centers for Disease Control and ...

Continue Reading...
May 20 2022

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation. According to the researchers, the BAP1 mutation is ...

Continue Reading...
May 19 2022

Johnson & Johnson's Bankruptcy Plan to be Reviewed by Appellate Court

A Federal Appeals Court will revisit the controversial ruling allowing Johnson & Johnson to use the Texas Two-Step tactic to transfer individual talc lawsuits to mass bankruptcy claims. In February, a U.S. Bankruptcy Court Judge sided with ...

Continue Reading...
May 12 2022

Johnson & Johnson Rejects Vote to Stop Selling Talc

Johnson & Johnson voted against a proposal to end sales of its talc-based baby powder globally at its annual shareholder meeting on April 28, 2022. The company stopped selling talc-based baby powder in the US and Canada in 2020 after an ...

Continue Reading...
May 12 2022

Mark Your Calendars! Time to Register for Pacific Mesothelioma Center's 11th Annual 5k Walk/Hike for Mesothelioma!

The Pacific Meso Center’s 11th Annual Walk/Hike for Mesothelioma is coming up! The walk will be held on Sunday, September 25, 2022. You can either join other walkers at Kenneth Hahn Park in Baldwin Hills or choose to participate virtually with ...

Continue Reading...
May 9 2022

BAP1 Genetic Mutation in Mesothelioma Warrants New Treatment Approaches

The University of Hawaii Cancer Center has published novel research on the BAP1 genetic mutation found in an estimated 10% of patients with mesothelioma with the goal of better understanding the unique traits of carriers of the mutation. Michele ...

Continue Reading...
May 6 2022

Hyperthermic Intrathoracic Chemotherapy is Associated with Longer Survival in Mesothelioma Patients

Researchers in the U.K. have published a systemic review analyzing 598 pleural mesothelioma patients that have undergone hyperthermic intrathoracic chemotherapy (“HITHOC”) immediately following surgery in the hopes of eradicating ...

Continue Reading...
May 6 2022

Chlorine Industry Opposes EPA Proposal to Ban Chrysotile Asbestos

Last month the Environmental Protection Agency under the Biden Administration announced a landmark proposal to ban the use, manufacture and import of Chrysotile asbestos in the United States, a move long coming since the US halted production of the ...

Continue Reading...
Apr 29 2022

Tackling the Asbestos that Lingers Behind in Buildings

Despite the recent EPA proposed ban on the use, manufacture and import of Chrysotile asbestos, the U.S. still faces the ongoing crisis of confronting the asbestos that remains in public buildings and homes. Also known as “legacy” ...

Continue Reading...
Apr 28 2022

Johnson & Johnson Shareholders to Vote to End Sales of Talc-Based Baby Powder Worldwide

Johnson & Johnson is being forced into a shareholder vote today, Thursday, April 28, at its 2022 Annual Shareholder meeting to end all sales of its talc-based baby powder globally. The company ceased sales of the product in the US and Canada in ...

Continue Reading...
Apr 28 2022

Must-See HBO Documentary Series Features Asbestos in Cosmetics

HBO’s new documentary series, Not So Pretty, takes a critical investigative look at the beauty industry and the numerous health risks associated with certain cosmetics products. The first episode, “Makeup,” highlights the hidden ...

Continue Reading...
Apr 26 2022

7th Annual Greatest Escape Motorcycle Generates over $45,000 for Research!

On Saturday, April 16 th, over 100 riders took part in the 7 th Annual Greatest Escape Motorcycle Rally for Mesothelioma Research. Worthington & Caron was proud to once again serve as lead sponsor and participate in this one-of-a-kind motorcycle ...

Continue Reading...
Apr 19 2022

EPA Proposes Banning Chrysotile Asbestos

The Environmental Protection Agency recently proposed banning the use, manufacture and import of Chrysotile asbestos, the most ubiquitous type of asbestos. The landmark proposal intending to restrict asbestos, signals the first time the federal ...

Continue Reading...
Mar 16 2022

Johnson & Johnson's Controversial Prison Experiments Revealed

Unsealed documents from more than 50 years ago, reveal that Johnson & Johnson funded experiments on prison inmates to examine the effects of talc. Bloomberg News reports that J&J’s involvement in these controversial talc studies was not ...

Continue Reading...
Feb 24 2022

$5M Awarded to Retired Contractor Exposed to Asbestos from Drywall Products

The asbestos attorneys of Worthington & Caron, P.C. are pleased to report that on February 16, 2022, a Santa Monica Jury awarded $5 million to our clients in a case entitled Brooks vs. Kaiser Gypsum Company, Inc., et al. (LASC Case No. ...

Continue Reading...
Feb 21 2022

Senator Durbin Blasts Johnson & Johnson's Bankruptcy Plan

Speaking from the U.S. Senate floor on February 15, Sen. Dick Durbin condemned Johnson & Johnson’s controversial bankruptcy strategy, which he labeled “shameful and indefensible”, to limit their massive legal liability to ...

Continue Reading...
Feb 21 2022

Johnson & Johnsons Plan to Limit Compensation to Talc Plaintiffs Revealed

Once again leading the charge, Reuters issued a special report detailing the bombshell story of how Johnson & Johnson strategized the plan to limit compensation to asbestos talc victims. Back in 2018, Reuters published an investigative report ...

Continue Reading...
Jan 21 2022

FDA To Propose Updated Regulations For Talc-Containing Products

Last week the U.S. Food and Drug Administration, in conjunction with their Interagency Working Group on Asbestos in Consumer Products, released a document containing the opinions of scientific experts suggesting changes to the FDA’s current ...

Continue Reading...
Jan 18 2022

New Immunotherapy Clinical Trial for Unresectable Meso

The National Cancer Institute is currently recruiting malignant pleural or peritoneal mesothelioma patients for a phase I clinical trial aimed at patients unable to undergo surgery and who have not responded to standard first-line treatments for ...

Continue Reading...
130 results found. Viewing page 1 of 6. Go to page 1 2 3 4 5 6   Next

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Speak with an Attorney